Previously, another SCFA, i.e., butyrate, has been reported to have therapeutic potential for RA.61 We also tested the effects of butyrate monotherapy or its combination with an anti-TNF etanercept for treatment of arthritis in CIA mice (Fig. 6a). This evidence concerns the gene TNF and arthritic joint disease.